{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Early Endovenous Ablation for Venous Leg Ulcers: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomised 1:1 to early intervention or deferred intervention"
      },
      "Participants": {
        "score": 2,
        "evidence": "450 participants with venous leg ulcers of less than 6 months' duration and superficial venous reflux"
      },
      "Intervention": {
        "score": 2,
        "evidence": "early intervention (compression therapy and endovenous ablation within 2 weeks) or deferred intervention (compression therapy with deferred ablation)"
      },
      "Objective": {
        "score": 1,
        "evidence": "assessed the clinical and cost-effectiveness of early endovenous ablation of superficial venous reflux in patients with venous leg ulceration"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was time to first ulcer recurrence, measured over a median follow-up of 1286 days"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomisation used permuted blocks, and allocation was not concealed"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applied to surgeons, participants, or follow-up assessors"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of 450 participants, 224 were randomised to early intervention and 226 to deferred intervention"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis included 426 participants whose ulcers healed, using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "No significant difference in time to first ulcer recurrence was observed (HR, 0.82; 95% CI, 0.57-1.17; P = .28)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial Registration: ISRCTN02335796"
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: UK National Institute for Health Research"
      }
    },
    "total_score": 19,
    "max_score": 25
  },
  "model": "gpt-4o"
}